CLINICAL_TRIALS
trial_result
· 2014-05-14
Clinical Trial Update: Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy [Phase 4]
Summary
A Phase 4 clinical trial update reports on the efficacy of dexmedetomidine in preventing contrast-induced nephropathy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: TC Erciyes University | Conditions: Radiographic Contrast Agent Nephropathy | Phase 4 | Status: COMPLETED